搜索医生

Min Shi, M.D., Ph.D.

  1. Hematopathologist
预约门诊

出版物

  1. Jevremovic D, Shi M, Horna P, Otteson GE, Timm MM, Bennett SA, Baughn LB, Greipp PT, Gonsalves WI, Kapoor P, Gertz MA, Binder M, Buadi FK, Dispenzieri A, Kourelis T, Muchtar E, Zhou J, Rajkumar SV, Kumar SK, Olteanu H. FDA IDE validation of multiple myeloma MRD test by flow cytometry. Am J Hematol 2024 Dec; 99 (12):2399-2401 Epub 2024 Sept 18
    View PubMed
  2. Shi M, Morice WG. How I diagnose large granular lymphocytic leukemia. Am J Clin Pathol. 2024 Nov 4; 162 (5):433-449
    View PubMed
  3. Baranwal A, Shah MV, Greipp P, Shi M, Reichard KK, Jevremovic D, Gangat N, Patnaik MM, Begna KH, Alkhateeb HB, Litzow MR, Hogan WJ, Tefferi A, Al-Kali A, Mangaonkar AA. Clinicopathologic correlates and prognostic impact of lymphoid aggregates in patients with myelodysplastic syndromes. Br J Haematol 2024 Oct; 205 (4):1627-1631 Epub 2024 July 31
    View PubMed
  4. Koehler AB, Rabe KG, Crusan DJ, Call TG, Achenbach SJ, Hampel PJ, Kenderian SS, Leis JF, Wang Y, Muchtar E, Tsang M, Hilal T, Parrondo R, Bailey KR, Ding W, Bailen R, Schwager SM, Shi M, Hanson CA, Slager SL, Kay NE, Ashrani AA, Parikh SA. Incidence, risk factors, and outcomes of patients with monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia who develop venous thromboembolism. J Thromb Haemost. 2024 Sep 27 Epub 2024 Sept 27
    View PubMed
  5. Gagnon MF, Meyer RG, Weaver EJ, Wood AJ, Dupuy DA Jr, Menachery SJ, Shi M, Baughn LB, Ketterling RP, Peterson JF. High-grade B-cell lymphoma with a quadruple-hit genetic profile including concurrent MYC, BCL2, BCL6, and CCND1 gene rearrangements. Lab Med. 2024 Sep 4; 55 (5):649-654
    View PubMed
  6. Shi M, Weybright MJ, Otteson GE, Jevremovic D, Olteanu H, Horna P. Appropriate interpretation of TRBC1-dim positive subsets in T-cell immunophenotyping by flow cytometry. Cytometry B Clin Cytom 2024 Sep 2 Epub 2024 Sept 02
    View PubMed
  7. Gunaratne MDSK, Shi M, Go RS. A comprehensive review on gelatinous transformation of the bone marrow. Expert Rev Hematol. 2024 Sep; 17 (9):547-554 Epub 2024 July 31
    View PubMed
  8. Wang J, Zhang W, Xu X, Buglioni A, Li P, Chen X, Liu Y, Xu M, Herrick JL, Horna P, Zhang X, Song J, Jevremovic D, He R, Shi M, Yuan J. Clinicopathologic features and outcomes of acute leukemia harboring PICALM::MLLT10 fusion. Hum Pathol. 2024 Sep; 151:105626 Epub 2024 July 04
    View PubMed
  9. Monaghan SA, Eck S, Bunting S, Dong XX, Durso RJ, Gonneau C, Hays A, Illingworth A, League SC, Linskens E, McCausland M, McCloskey TW, Rolf N, Shi M, Wallace PK, Litwin V, Kern W, Deeb G, Nash V, Olteanu H. Flow cytometry assay modifications: Recommendations for method validation based on CLSI H62 guidelines. Cytometry B Clin Cytom. 2024 Aug 21 [Epub ahead of print]
    View PubMed
  10. Jevremovic D, Shi M, Horna P, Otteson GE, Timm MM, Baughn LB, Greipp PT, Gonsalves WI, Kapoor P, Gertz MA, Binder M, Buadi FK, Zhou J, Dispenzieri A, Kourelis T, Muchtar E, Rajkumar SV, Kumar SK, Olteanu H. Real-life sensitivity of flow cytometry minimal residual disease assessment for plasma cell neoplasms. Blood Cancer J 2024 Jul 31; 14 (1):126 Epub 2024 July 31
    View PubMed
  11. Seheult JN, Weybright MJ, Jevremovic D, Shi M, Olteanu H, Horna P. Computational Flow Cytometry Accurately Identifies Sezary Cells Based on Simplified Aberrancy and Clonality Features. J Invest Dermatol. 2024 Jul; 144 (7):1590-1599.e3 Epub 2024 Jan 17
    View PubMed
  12. Wang H, Tian S, Secreto CR, Sinha S, Shi M, Call T, Wang Y, Parikh SA, Kenderian SS, He R, Leis JF, VanDyke DL, Klee EW, Slager SL, Braggio E, Yan H, Ding W. Clonal dynamics of Richter transformation in chronic lymphocytic leukemia. Hematol Oncol 2024 Jul; 42 (4):e3282
    View PubMed
  13. Shi M, Yuan J. Pseudo-Richter Transformation of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma After Temporary Acalabrutinib Interruption. Mayo Clin Proc 2024 Jun; 99 (6):867-868 Epub 2024 Apr 30
    View PubMed
  14. Horna P, Weybright MJ, Ferrari M, Jungherz D, Peng Y, Akbar Z, Tudor Ilca F, Otteson GE, Seheult JN, Ortmann J, Shi M, Maciocia PM, Herling M, Pule MA, Olteanu H. Dual T-cell constant beta chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry. Blood Cancer J. 2024 Feb 29; 14 (1):34
    View PubMed
  15. Zhou T, Curry CV, Khanlari M, Shi M, Cui W, Peker D, Chen W, Wang E, Gao J, Shen Q, Xie W, Jelloul FZ, King RL, Yuan J, Wang X, Zhao C, Obiorah IE, Courville EL, Nomura E, Cherian S, Xu ML, Burack WR, Liu HX, Jabbour EJ, Takahashi K, Wang W, Wang SA, Khoury JD, Medeiros LJ, Hu S. Genetics and pathologic landscape of lineage switch of acute leukemia during therapy. Blood Cancer J 2024 Jan 25; 14 (1):19
    View PubMed
  16. Gagnon MF, Midthun SM, Fangel JA, Schuh CM, Luoma IM, Pearce KE, Meyer RG, Ailawadhi S, Arribas MJ, Braggio E, Fonseca R, Rajkumar SV, Zepeda-Mendoza C, Xu X, Greipp PT, Timm MM, Otteson GE, Shi M, Jevremovic D, Olteanu H, Peterson JF, Ketterling RP, Kumar S, Baughn LB. Superior detection rate of plasma cell FISH using FACS-FISH. Am J Clin Pathol. 2024 Jan 4; 161 (1):60-70
    View PubMed
  17. Bruehl FK, Norgan AP, Shi M, Rech KL, Ding Y, Pittaluga S, Yuan J. Concurrent T-cell/histiocyte-rich large B-cell lymphoma and HHV-6A-infected T-cell proliferation: a diagnostic pitfall. Histopathology 2023 Dec; 83 (6):999-1002 Epub 2023 Sept 04
    View PubMed
  18. Fadl A, Oishi N, Shi M, Dasari S, Ansell SM, Ketterling RP, Feldman AL. Anaplastic large cell lymphomas with equivocal DUSP22 FISH results: recommendations for clinical reporting and diagnostic evaluation. Hum Pathol. 2023 Nov; 141:6-14 Epub 2023 Aug 24
    View PubMed
  19. Yuan J, Liu H, Hu S, Miranda RN, Xu X, Bayerl MG, Artymiuk CJ, Berg H, King RL, Shi M, He R, Viswanatha D, Medeiros LJ, McPhail ED. Follicular lymphoma and diffuse large B-cell lymphoma with BCL2 and IRF4 rearrangements in adult patients. Hum Pathol. 2023 Nov; 141:22-29 Epub 2023 Aug 25
    View PubMed
  20. Zhang X, Shi M. Extensive Hemophagocytic Lymphohistiocytosis Associated With Aggressive Natural Killer Cell Leukemia. Mayo Clin Proc. 2023 Sep; 98 (9):1345-1346
    View PubMed
  21. Abdelmagid MG, Al-Kali A, Begna KH, Hogan WJ, Litzow MR, Fleti F, Mangaonkar AA, Patnaik MS, Elliott MA, Alkhateeb H, Shi M, Howard MT, Reichard KK, Ketterling RP, Shah M, Pardanani A, Gangat N, Tefferi A. Blast phase myeloproliferative neoplasm with prior exposure to ruxolitinib: comparative analysis of mutations and survival. Haematologica 2023 Sep 1; 108 (9):2542-2545 Epub 2023 Sept 01
    View PubMed
  22. Seheult JN, Otteson GE, Jevremovic D, Horna P, Timm MM, Yuan J, Morice WG, Olteanu H, Shi M. Establishing NK-Cell Receptor Restriction by Flow Cytometry and Detecting Potential NK-Cell Clones of Uncertain Significance. Mod Pathol. 2023 Aug; 36 (8):100255 Epub 2023 June 28
    View PubMed
  23. Marell PS, Shi M, Wingo MT. Primary hepatic Epstein-Barr virus-positive diffuse large B-cell lymphoma associated with azathioprine immunosuppression: a case report. J Med Case Rep. 2023 May 2; 17 (1):175 Epub 2023 May 02
    View PubMed
  24. Panakkal V, Lakshman A, Shi M, Olteanu H, Horna P, Timm MM, Otteson GE, Baughn LB, Greipp PT, Gonsalves WI, Kapoor P, Gertz MA, Binder M, Buadi FK, Dispenzieri A, Rajkumar SV, Kumar SK, Jevremovic D. Utility of flow cytometry screening before MRD testing in multiple myeloma. Blood Cancer J 2023 Apr 20; 13 (1):55
    View PubMed
  25. Barila G, Grassi A, Cheon H, Teramo A, Calabretto G, Chahal J, Vicenzetto C, Almeida J, Shemo BC, Shi M, Gasparini VR, Munoz-Garcia N, Pastoret C, Nakazawa H, Oshimi K, Sokol L, Ishida F, Lamy T, Orfao A, Morice WG, Loughran TP, Semenzato G, Zambello R. Tgammadelta LGLL identifies a subset with more symptomatic disease: analysis of an international cohort of 137 patients. Blood. 2023 Mar 2; 141 (9):1036-1046
    View PubMed
  26. Horna P, Otteson G, Shi M, Seheult JN, Jevremovic D, Olteanu H. Improved semiautomated detection of TRBC-restricted Sezary cells unveils a spectrum of clonal cluster immunophenotypes. Blood. 2022 Dec 29; 140 (26):2852-2856
    View PubMed
  27. Feldman AL, Oishi N, Ketterling RP, Ansell SM, Shi M, Dasari S. Immunohistochemical Approach to Genetic Subtyping of Anaplastic Large Cell Lymphoma. Am J Surg Pathol. 2022 Nov 1; 46 (11):1490-1499 Epub 2022 Aug 08
    View PubMed
  28. Yang S, Kay NE, Shi M, Hanson CA, Gale RP. Is unmeasurable residual disease (uMRD) the best surrogate endpoint for clinical trials, regulatory approvals and therapy decisions in chronic lymphocytic leukaemia (CLL)? Leukemia. 2022 Nov; 36 (11):2743-2747 Epub 2022 Sept 13
    View PubMed
  29. Jevremovic D, Nanaa A, Geyer SM, Timm M, Azouz H, Hengel C, Reberg A, He R, Viswanatha D, Salama ME, Shi M, Olteanu H, Horna P, Otteson G, Greipp PT, Xie Z, Alkhateeb HB, Hogan W, Litzow M, Patnaik MM, Shah M, Al-Kali A, Nguyen PL. Abnormal CD13/HLA-DR Expression Pattern on Myeloblasts Predicts Development of Myeloid Neoplasia in Patients With Clonal Cytopenia of Undetermined Significance. Am J Clin Pathol. 2022 Oct 6; 158 (4):530-536
    View PubMed
  30. Hampel PJ, Rabe KG, Call TG, Ding W, Leis JF, Kenderian SS, Muchtar E, Wang Y, Koehler AB, Parrondo R, Schwager SM, Shi M, Braggio E, Slager SL, Kay NE, Parikh SA. Combined ibrutinib and venetoclax for treatment of patients with ibrutinib-resistant or double-refractory chronic lymphocytic leukaemia. Br J Haematol. 2022 Oct; 199 (2):239-244 Epub 2022 July 16
    View PubMed
  31. Hampel PJ, Rabe KG, Call TG, Ding W, Leis JF, Chanan-Khan AA, Kenderian SS, Muchtar E, Wang Y, Ailawadhi S, Koehler AB, Parrondo R, Schwager SM, Sher T, Hanson CA, Shi M, Van Dyke DL, Braggio E, Slager SL, Kay NE, Parikh SA. Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib. Blood Cancer J. 2022 Sep 1; 12 (9):124 Epub 2022 Sept 01
    View PubMed
  32. Ravindran A, Said S, Shi M. Thinking Beyond the Marrow: Deceptive Presentation of a Rare Malignant Neoplasm. Mayo Clin Proc. 2022 Jul; 97 (7):1337-1338
    View PubMed
  33. Ravindran A, Kurtin PJ, King RL, Yuan J, Feldman AL, Rech KL, McPhail ED, Parikh SA, Ding W, Shi M. Aberrant expression of lymphoid enhancer-binding factor 1 in Hodgkin lymphoma. Hum Pathol. 2022 Jul; 125:2-10. Epub 2022 Apr 12.
    View PubMed
  34. Shi M, Timm MM, Howard MT, Jevremovic D, Yuan J, Greipp PT, Peterson JF, Roh DJ, Horna P, Olteanu H. Spurious CD34 expression in B-cell lymphoma due to nonspecific binding to PerCP-Cy5.5 fluorochrome conjugates: A rare phenomenon and a diagnostic pitfall. Cytometry B Clin Cytom 2022 Jul; 102 (4):326-328 Epub 2022 June 02
    View PubMed
  35. Matsumoto NP, Yuan J, Wang J, Shen Q, Chen X, Kim Y, Zuppan CW, Chang CC, Cui W, Chen D, Shi M, Gisriel SD, Chen M, Xu ML, Pan Z. Mast cell sarcoma: clinicopathologic and molecular analysis of 10 new cases and review of literature. Mod Pathol. 2022 Jul; 35 (7):865-874 Epub 2022 Feb 01
    View PubMed
  36. Huang Y, Hu S, Larson DP, Shi M, He R, Dave BJ, Greiner TC, Fu K, McPhail ED, Ketterling RP, Medeiros LJ, Yuan J. Composite Classic Hodgkin Lymphoma and Follicular Lymphoma: A Clinicopathologic Study of 22 Cases With Review of 27 Additional Cases in the Literature. Am J Surg Pathol. 2022 Jun 01; 46(6):793-800. Epub 2022 Jan 24.
    View PubMed
  37. Salama ME, Otteson GE, Camp JJ, Seheult JN, Jevremovic D, Holmes DR 3rd, Olteanu H, Shi M. Artificial Intelligence Enhances Diagnostic Flow Cytometry Workflow in the Detection of Minimal Residual Disease of Chronic Lymphocytic Leukemia. Cancers (Basel). 2022 May 21; 14 (10)
    View PubMed
  38. Wang H, Tian S, Zhao Q, Blumenschein W, Yearley JH, Secreto CR, Sinha S, Call TG, Wang Y, Parikh SA, Kenderian SS, He R, Leis JF, Shi M, Van Dyke DL, Kay NE, Slager SL, Braggio E, Yan H, Ding W. Differential transcriptomic profiling in ibrutinib-naive versus ibrutinib-resistant Richter syndrome. Hematol Oncol 2022 Apr; 40 (2):302-306 Epub 2021 Dec 03
    View PubMed
  39. Camp J, Otteson G, Seheult J, Shi M, Jevremovic D, Olteanu H, Nanaa A, Al-Kali A, Salama M, Holmes D. Deep Neural Network for Cell Type Differentiation in Myelodysplastic Syndrome Diagnosis Performs Similarly when Trained on Compensated or Uncompensated Data. Proceedings of the Medical Imaging 2022: Digital and Computational Pathology. 2022.
  40. Soh KT, Came N, Otteson GE, Jevremovic D, Shi M, Olteanu H, Natoni A, Lagoo A, Theakston E, Oskarsson JThorn, Gorniak M, Grigoriadis G, Arroz M, Fletcher M, Lin P, Ludwig P, Tembhare P, Matuzeviciene R, Radzevicius M, Kay S, Chen W, Cabrita C, Wallace PK. Evaluation of multiple myeloma measurable residual disease by high sensitivity flow cytometry: An international harmonized approach for data analysis. Cytometry B Clin Cytom. 2022 Mar; 102 (2):88-106 Epub 2022 Jan 10
    View PubMed
  41. Salama Y, Zhao F, Oliveira JL, Yuan J, Jevremovic D, Go RS, Ding W, Parikh SA, Shah MV, Hampel PJ, Al-Kali A, Morice WG, Shi M. Isolated anemia in patients with large granular lymphocytic leukemia (LGLL). Blood Cancer J. 2022 Feb 22; 12 (2):30
    View PubMed
  42. Horna P, Pearce KE, Ketterling RP, Shi M, Peterson JF. Recurrent Chromosomal Abnormalities in Tissues Involved by Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Am J Clin Pathol. 2022 Feb 3; 157 (2):286-292
    View PubMed
  43. Nelson ED, Larson E, Joo DJ, Mao S, Glorioso J, Abu Rmilah A, Zhou W, Jia Y, Mounajjed T, Shi M, Bois M, Wood A, Jin F, Whitworth K, Wells K, Spate A, Samuel M, Minshew A, Walters E, Rinaldo P, Lillegard JB, Johnson A, Amiot B, Hickey R, Prather R, Platt JL, Nyberg SL. Limited Expansion of Human Hepatocytes in FAH/RAG2-Deficient Swine. Tissue Eng Part A. 2022 Feb; 28(3-4):150-160. Epub 2021 Oct 07.
    View PubMed
  44. King RL, Gupta A, Kurtin PJ, Ding W, Call TG, Rabe KG, Kenderian SS, Leis JF, Wang Y, Schwager SM, Slager SL, Kay NE, Koehler A, Ansell SM, Inwards DJ, Habermann TM, Shi M, Hanson CA, Howard MT, Parikh SA. Chronic lymphocytic leukemia (CLL) with Reed-Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter? Blood Cancer J. 2022 Jan 28; 12 (1):18
    View PubMed
  45. Horna P, Otteson GE, Shi M, Jevremovic D, Yuan J, Olteanu H. Flow Cytometric Evaluation of Surface and Cytoplasmic TRBC1 Expression in the Differential Diagnosis of Immature T-Cell Proliferations. Am J Clin Pathol. 2022 Jan 6; 157 (1):64-72
    View PubMed
  46. Yang S, Kay NE, Shi M, Ossenkoppele G, Walter RB, Gale RP. Measurable residual disease testing in chronic lymphocytic leukaemia: hype, hope neither or both? Leukemia 2021 Dec; 35 (12):3364-3370 Epub 2021 Sept 27
    View PubMed
  47. Rangan A, Hein MS, Jenkinson WG, Koganti T, Aleff RA, Hilker CA, Blommel JH, Porter TR, Swanson KC, Lundquist P, Nguyen PL, Shi M, He R, Viswanatha DS, Jen J, Klee EW, Kipp BR, Hoyer JD, Wieben ED, Oliveira JL. Improved Characterization of Complex beta-Globin Gene Cluster Structural Variants Using Long-Read Sequencing. J Mol Diagn. 2021 Dec; 23 (12):1732-1740
    View PubMed
  48. Panda A, McCarthy MR, Murray JA, Sharain RF, Shi M, Kendi AT. Incidentally Detected Celiac Disease with Splenomegaly on (18)F FDG PET/CT: A Potential Lymphoma Mimic. Asia Ocean J Nucl Med Biol. 2021 Winter; 9 (1):51-55
    View PubMed
  49. Zheng G, He R, Reichard KK, Peterson JF, Olteanu H, Oliveira JL, Rangan A, Chen D, Shi M. Genetic and Clinical Studies of Patients With Increased Multinucleated Megakaryocytes in Bone Marrow as an Isolated Finding: A Diagnostic Pitfall for Myelodysplastic Syndrome. Am J Surg Pathol. 2021 Nov 1; 45 (11):1534-1540
    View PubMed
  50. Rozenova KA, Jevremovic D, Reichard KK, Nguyen P, Otteson GE, Timm MM, Horna P, Olteanu H, Shi M. CD2 and CD7 are sensitive flow cytometry screening markers for T-lineage acute leukemia(s): a study of 465 acute leukemia cases. Hum Pathol. 2021 Aug; 114:66-73 Epub 2021 May 18
    View PubMed
  51. Rangan A, Savedra ME, Dergam-Larson C, Swanson KC, Szuberski J, Go RS, Porter TR, Brunker SE, Shi M, Nguyen PL, Hoyer JD, Oliveira JL. Interpreting sulfhemoglobin and methemoglobin in patients with cyanosis: An overview of patients with M-hemoglobin variants. Int J Lab Hematol. 2021 Aug; 43 (4):837-844 Epub 2021 June 06
    View PubMed
  52. Horna P, Olteanu H, Jevremovic D, Otteson GE, Corley H, Ding W, Parikh SA, Shah MV, Morice WG, Shi M. Single-Antibody Evaluation of T-Cell Receptor beta Constant Chain Monotypia by Flow Cytometry Facilitates the Diagnosis of T-Cell Large Granular Lymphocytic Leukemia. Am J Clin Pathol. 2021 Jun 17; 156 (1):139-148
    View PubMed
  53. Audil HY, Hampel PJ, Van Dyke DL, Achenbach SJ, Rabe KG, Smoley SA, Call TG, Ding W, Shi M, Hanson CA, Wang Y, Muchtar E, Koehler AB, Schwager SM, Leis JF, Braggio E, Slager SL, Kay NE, Kenderian SS, Parikh SA. The prognostic significance of del6q23 in chronic lymphocytic leukemia. Am J Hematol 2021 Jun 1; 96 (6):E203-E206 Epub 2021 Apr 07
    View PubMed
  54. Rozenova K, Shi M. Medication-induced Pseudo-Pelger-Huët Anomaly and severe neutropenia Journal of Hematopathology. 2021.
  55. Berg H, Otteson GE, Corley H, Shi M, Horna P, Jevremovic D, Olteanu H. Flow cytometric evaluation of TRBC1 expression in tissue specimens and body fluids is a novel and specific method for assessment of T-cell clonality and diagnosis of T-cell neoplasms. Cytometry B Clin Cytom. 2021 May; 100 (3):361-369 Epub 2020 Apr 25
    View PubMed
  56. Horna P, Shi M, Jevremovic D, Craig FE, Comfere NI, Olteanu H. Utility of TRBC1 Expression in the Diagnosis of Peripheral Blood Involvement by Cutaneous T-Cell Lymphoma. J Invest Dermatol. 2021 Apr; 141 (4):821-829.e2 Epub 2020 Oct 10
    View PubMed
  57. Ravindran A, Feldman AL, Ketterling RP, Dasari S, Rech KL, McPhail ED, Kurtin PJ, Shi M. Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 Rearrangements in Anaplastic Large Cell Lymphoma. Am J Surg Pathol. 2021 Apr 1; 45 (4):550-557
    View PubMed
  58. Hampel PJ, Parikh SA, Call TG, Shah MV, Bennani NN, Al-Kali A, Rabe KG, Wang Y, Muchtar E, Leis JF, Kenderian SS, Koehler AB, Schwager SM, Slager SL, Kay NE, Hanson CA, Van Dyke DL, Shi M, Ding W. Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia. Blood Cancer J 2021 Mar 2; 11 (3):47 Epub 2021 Mar 02
    View PubMed
  59. Horna P, Shi M, Olteanu H, Johansson U. Emerging Role of T-cell Receptor Constant beta Chain-1 (TRBC1) Expression in the Flow Cytometric Diagnosis of T-cell Malignancies. Int J Mol Sci. 2021 Feb 12; 22 (4)
    View PubMed
  60. Berg HE, Blackburn PR, Baughn LB, Ketterling RP, Xu X, Greipp PT, Hoppman NL, Smadbeck JB, Vasmatzis G, Shi M, Reichard KK, Viswanatha DS, Jevremovic D, Maher GM, Peterson JF. Identification of a novel KMT2A/GIMAP8 gene fusion in a pediatric patient with acute undifferentiated leukemia. Genes Chromosomes Cancer. 2021 Feb; 60 (2):108-111 Epub 2020 Oct 21
    View PubMed
  61. Wang Y, Rabe KG, Bold MS, Shi M, Hanson CA, Schwager SM, Call TG, Kenderian SS, Muchtar E, Hayman SR, Koehler AB, Fonder AL, Chanan-Khan AA, Van Dyke DL, Slager SL, Kay NE, Ding W, Leis JF, Parikh SA. The role of 18F-FDG-PET in detecting Richter's transformation of chronic lymphocytic leukemia in patients receiving therapy with a B-cell receptor inhibitor. Haematologica 2020 Nov 1; 105 (11):2675-2678 Epub 2020 Nov 01
    View PubMed
  62. Shi M, Nguyen P, Timm MM, Otteson GE, Horna P, Olteanu H, Jevremovic D. Cytoplasmic Expression of CD3epsilon Heterodimers by Flow Cytometry Rapidly Distinguishes Between Mature T-Cell and Natural Killer-Cell Neoplasms. Am J Clin Pathol. 2020 Oct 13; 154 (5):683-691
    View PubMed
  63. Shi M, Olteanu H, Jevremovic D, He R, Viswanatha D, Corley H, Horna P. T-cell clones of uncertain significance are highly prevalent and show close resemblance to T-cell large granular lymphocytic leukemia. Implications for laboratory diagnostics. Mod Pathol. 2020 Oct; 33 (10):2046-2057 Epub 2020 May 13
    View PubMed
  64. Vaughan JW, Shi M, Horna P, Olteanu H. Increased CD200 expression in post-transplant lymphoproliferative disorders correlates with an increased frequency of FoxP3(+) regulatory T cells. Ann Diagn Pathol. 2020 Oct; 48:151585 Epub 2020 Aug 14
    View PubMed
  65. Mehta N, Johnston JM, Hein M, Kipp BR, Coon L, Savedra ME, Hoyer JD, He R, Rangan A, Shi M, Oliveira JL. Further Characterization of Hb Bronovo [alpha103(G10)His-->Leu; HBA2: c.311A>T] and First Report of the Homozygous State. Hemoglobin. 2020 May; 44 (3):174-178 Epub 2020 June 18
    View PubMed
  66. Shi M, Rech KL, Otteson GE, Horna P, Olteanu H, Pardanani A, Chen D, Jevremovic D. Prevalence and spectrum of T-cell lymphoproliferative disorders in patients with Hypereosinophilia: A reference laboratory experience. Ann Diagn Pathol. 2020 Feb; 44:151412 Epub 2019 Oct 18
    View PubMed
  67. Ravindran A, He R, Ketterling RP, Jawad MD, Chen D, Oliveira JL, Nguyen PL, Viswanatha DS, Reichard KK, Hoyer JD, Go RS, Shi M. The significance of genetic mutations and their prognostic impact on patients with incidental finding of isolated del(20q) in bone marrow without morphologic evidence of a myeloid neoplasm. Blood Cancer J. 2020 Jan 23; 10 (1):7
    View PubMed
  68. Shi M, Jevremovic D, Otteson GE, Timm MM, Olteanu H, Horna P. Single Antibody Detection of T-Cell Receptor alphabeta Clonality by Flow Cytometry Rapidly Identifies Mature T-Cell Neoplasms and Monotypic Small CD8-Positive Subsets of Uncertain Significance. Cytometry B Clin Cytom. 2020 Jan; 98 (1):99-107 Epub 2019 Apr 11
    View PubMed
  69. Jung S, Wengenack N, Shi M, Schuetz AN. Photo Quiz: Rapidly Progressive Pneumonia in a Resident of the U.S. Midwest. J Clin Microbiol 2019 Dec 23; 58 (1)
    View PubMed
  70. Smadbeck J, Peterson JF, Pearce KE, Pitel BA, Figueroa AL, Timm M, Jevremovic D, Shi M, Stewart AK, Braggio E, Riggs DL, Bergsagel PL, Vasmatzis G, Kearney HM, Hoppman NL, Ketterling RP, Kumar S, Rajkumar SV, Greipp PT, Baughn LB. Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma. Blood Cancer J. 2019 Dec 16; 9 (12):103
    View PubMed
  71. Peterson JF, Ketterling RP, Huang L, Finn LE, Shi M, Hoppman NL, Greipp PT, Baughn LB. A near-haploid clone harboring a BCR/ABL1 gene fusion in an adult patient with newly diagnosed B-lymphoblastic leukemia. Genes Chromosomes Cancer. 2019 Sep; 58 (9):665-668 Epub 2019 Mar 18
    View PubMed
  72. Basha BM, Bryant SC, Rech KL, Feldman AL, Vrana JA, Shi M, Reed KA, King RL. Application of a 5 Marker Panel to the Routine Diagnosis of Peripheral T-Cell Lymphoma With T-Follicular Helper Phenotype. Am J Surg Pathol. 2019 Sep; 43 (9):1282-1290
    View PubMed
  73. Pophali PA, Timm MM, Mangaonkar AA, Shi M, Shi M, Reichard K, Tefferi A, Pavelko K, Villasboas JC, Jevremovic D, Patnaik MM. Practical limitations of monocyte subset repartitioning by multiparametric flow cytometry in chronic myelomonocytic leukemia. Blood Cancer J 2019 Aug 16; 9 (9):65
    View PubMed
  74. Coffy S, Shi M. Giant intracytoplasmic inclusions in a T-cell large granular lymphocytic leukemia patient with acute severe anemia. Blood. 2019 Aug 1; 134 (5):492
    View PubMed
  75. Shi M, Dao L, Jevremovic D. Laboratory Work-Up of Chronic B-Cell Lymphoid Malignancies - A Value-Based Approach. Acta Med Acad. 2019 Apr; 48 (1):45-56
    View PubMed
  76. Shi M, Ternus JA, Ketterling RP, Jevremovic D, McPhail ED. Immunophenotypic and laboratory features of t(11;14)(q13;q32)-positive plasma cell neoplasms. Leuk Lymphoma. 2018 Aug; 59(8):1913-1919. Epub 2017 Dec 07.
    View PubMed
  77. Higgins L, Nasr SH, Said SM, Kapoor P, Dingli D, King RL, Rajkumar SV, Kyle RA, Kourelis T, Gertz MA, Dispenzieri A, Lacy MQ, Buadi FK, Ansell SM, Gonsalves WI, Thompson CA, Fervenza FC, Zand L, Hwa YL, Jevremovic D, Shi M, Leung N. Kidney Involvement of Patients with Waldenstrom Macroglobulinemia and Other IgM-Producing B Cell Lymphoproliferative Disorders. Clin J Am Soc Nephrol. 2018 Jul 6; 13 (7):1037-1046 Epub 2018 May 30
    View PubMed
  78. He R, Ding W, Viswanatha DS, Chen D, Shi M, Van Dyke D, Tian S, Dao LN, Parikh SA, Shanafelt TD, Call TG, Ansell SM, Leis JF, Mai M, Hanson CA, Rech KL. PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal Relatedness. Am J Surg Pathol. 2018 Jul; 42 (7):843-854
    View PubMed
  79. Rangan A, Oliveira JL, Jevremovic D, Morice WG, Chen D, Shi m. Pure red cell aplasia due to T-cell large granular lymphocytic leukemia after hematopoietic stem cell transplantation AJSP: Reviews & Reports.. 2018; 23(3):p e1-e4.
  80. Shi M, He R, Feldman AL, Viswanatha DS, Jevremovic D, Chen D, Morice WG. STAT3 mutation and its clinical and histopathologic correlation in T-cell large granular lymphocytic leukemia. Hum Pathol. 2018 Mar; 73:74-81 Epub 2017 Dec 27
    View PubMed
  81. Shi M, Ternus JA, Chen D. Greatly increased giant platelets mimicking blasts in flow cytometric analysis from a patient with primary myelofibrosis J Hematopathol. 2018; 11:21-22.
  82. Goyal T, Thakral B, Wang SA, Bueso-Ramos CE, Shi M, Jevremovic D, Morice WG, Zhang QY, George TI, Foucar KK, Bhattacharyya S, Bagg A, Rogers HJ, Bodo J, Durkin L, Hsi ED. T-Cell Large Granular Lymphocytic Leukemia and Coexisting B-Cell Lymphomas: A Study From the Bone Marrow Pathology Group. Am J Clin Pathol. 2018 Jan 29; 149(2):164-171.
    View PubMed
  83. Neff JL, Rangan A, Jevremovic D, Nguyen PL, Chiu A, Go RS, Chen D, Morice WG, Shi M. Mixed-phenotype large granular lymphocytic leukemia: a rare subtype in the large granular lymphocytic leukemia spectrum Human Pathology. 2018; 81:96-104
  84. Shi M, Nguyen P, Jevremovic D. Flow Cytometric Assessment of Chronic Myeloid Neoplasms. Clin Lab Med. 2017 Dec; 37 (4):803-819 Epub 2017 Sept 20
    View PubMed
  85. Haddox CL, Mangaonkar AA, Chen D, Shi M, He R, Oliveira JL, Litzow MR, Al-Kali A, Hogan WJ, Elliott MA. Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis. Blood Cancer J 2017 Sep 15; 7 (9):e607 Epub 2017 Sept 15
    View PubMed
  86. Patnaik MM, Timm MM, Vallapureddy R, Lasho TL, Ketterling RP, Gangat N, Shi M, Tefferi A, Solary E, Reichard KK, Jevremovic D. Flow cytometry based monocyte subset analysis accurately distinguishes chronic myelomonocytic leukemia from myeloproliferative neoplasms with associated monocytosis. Blood Cancer J 2017 Jul 21; 7 (7):e584 Epub 2017 July 21
    View PubMed
  87. Huffman BM, Wiisanen J, Shi M, Go RS. Feeling run down: exercise-induced pancytopenia. Br J Haematol. 2017 Jun; 177 (5):672 Epub 2017 Apr 17
    View PubMed
  88. Shi M, Chen D. Erythrophagocytosis by neutrophils and megakaryocytic emperipolesis are distinctive morphologic features in del(20q)-associated myelodysplastic syndrome Human Pathology: Case Reports .2017;S2214-3300(16)30138-9.
  89. Jawad MD, Go RS, Reichard KK, Shi M. Increased Multinucleated Megakaryocytes as an Isolated Finding in Bone Marrow: A Rare Finding and Its Clinical Significance. Am J Clin Pathol. 2016 Nov 1; 146 (5):561-566
    View PubMed
  90. Partain DK, Botero JP, Shi M, Poterucha JJ, Ashrani AA, Thompson CA. Spur cell anemia in the setting of progressive liver allograft failure. Am J Hematol. 2016 Oct; 91(10):1061. Epub 2016 Mar 22.
    View PubMed
  91. Jawad MD, Shi M, Oliveira JL, Hoyer JD, Christopher Hook C, Go RS. Clinical course of patients with incidental finding of 20q- in the bone marrow without a morphologic evidence of myeloid neoplasm. Am J Hematol. 2016 Jun; 91 (6):556-9 Epub 2016 Apr 06
    View PubMed
  92. Shi M, Neff JL, Jevremovic D, Morice WG. Decreased normal NK-cells is a characteristic of T-cell large granular lymphocytic leukemia and is strongly associated with cytopenia. Leuk Lymphoma 2016 May; 57 (5):1230-3 Epub 2015 Dec 21
    View PubMed
  93. Jawad MD, Go RS, Ketterling RP, Begna KH, Reichard KK, Shi M. Transient monosomy 7 in a chronic myelogenous leukemia patient during nilotinib therapy: a case report. Clin Case Rep. 2016 Mar; 4 (3):282-6 Epub 2016 Feb 08
    View PubMed
  94. Shi M, He R. Plasma cell myeloma with numerous cytoplasmic granules. Blood. 2016 Feb 25; 127 (8):1073
    View PubMed
  95. Shi M, Savage NM, Salman H, Morice WG. A case of lymphoproliferative disorder of NK-cells: aggressive immunophenotype but indolent behavior. Clin Case Rep. 2015 Sep; 3 (9):740-3 Epub 2015 Aug 11
    View PubMed
  96. Shi M, Shahsafaei A, Liu C, Yu H, Dorfman DM. Enhancer of zeste homolog 2 is widely expressed in T-cell neoplasms, is associated with high proliferation rate and correlates with MYC and pSTAT3 expression in a subset of cases. Leuk Lymphoma. 2015 Jul; 56(7):2087-91. Epub 2014 Oct 30
    View PubMed
  97. Lee-Sarwar K, Vaidya A, Shi M, Akin C. INTERACTIVE MEDICAL CASE. A Stinging Sensation. N Engl J Med. 2015; 372(26):e35.
    View PubMed
  98. Shi M, Roemer MGM, Chapuy B, Liao X, Sun H, Pinkus GS, Shipp MA, Greeman GJ, Rodig SJ. Expression of Programmed Cell Death 1 Ligand 2 (PD-L2) is a Distinguishing Feature of Primary Mediastinal (Thymic) Large B-cell Lymphoma and Associated with PDCD1LG2 Copy Gain. Am J Surg Pathol. 2014; 38(12):1715-23.
    View PubMed
  99. Basile F, Shi M, Sullivan M. Solitary Plasmacytoma of the Uvula. Am J Hematol. 2014; 89(6):660-1.
    View PubMed
  100. Mane M, O'Neill, Tirumani SH, Shi M, Fisher D, Shinagare AB. Thyroid Lymphoma on a Background of Hashimoto's Thyroiditis: PET/CT Appearances. Clin Imaging. 2014; 38(6):864-7.
    View PubMed
  101. Shi M, Xiao R, Woda BA, Yu H. Five Important Advances in Hematopathology. Arch Pathol Lab Med. 2014; 138(3):410-19.
    View PubMed
  102. Shi M, Cipollini MJ, Crowley-Bish PA, Higgins AW, Yu H, Miron PM. Improved detection rate of cytogenetic abnormalities in chronic lymphocytic leukemia and other mature B-cell neoplasms with use of CpG-oligonucleotide DSP30 and interleukin 2 stimulation. Am J Clin Pathol. 2013 May; 139 (5):662-9
    View PubMed
  103. Cornejo KM, Shi M, Akakin A, Uy K, Cagle PT, Fraire AE. Pulmonary Papillary Adenoma: A Case Report and Review of the Literature. J Bronchology Interv Polmonol. 2013; 20(14):52-7.
    View PubMed
  104. Cornejo KM, Shi M, Jiang Z. Oncofetal Protein IMP3: A Useful Diagnostic Biomarker for Leiomyosarcoma. Hum Pathol. 2012 August; 43(10):1567-72.
    View PubMed
  105. Shi M, Miron PM, Hutchinson L, Woda BA, Nath R, Cerny J, Yu H. Anaplastic lymphoma kinase-positive large B-cell lymphoma with complex karyotype and novel ALK gene rearrangements. Hum Pathol. 2011 Oct; 42 (10):1562-7 Epub 2011 Apr 15
    View PubMed
  106. Shi M, Fraire AE, Chu P, Cornejo KM, Woda BA, Dresser K, Rock KL, Jiang Z. Oncofetal Protein IMP2, a New Diagnostic Biomarker to Distinguish Malignant Mesothelioma from Reactive Mesothelial Proliferation. Am J Surg Pathol. 2011; 35(6):878-82.
    View PubMed
  107. Wang W, Shin Y, Shi M, Kilpartick DL. Temporal Control of a Dendritogenesis-linked Gene via REST-dependent Regulation of Nuclear Factor I Occupancy. Mol Bio Cell. 2011; 22(6):868-79.
    View PubMed
  108. Shi M, Lin TH, Appell KC, Berg LJ. Cell Cycle Progression Following Naive T-cell Activation is Independent of Jak3/common gamma-chain Cytokine Signals. J Immunol. 2009; 83(7):4493-4501.
    View PubMed
  109. Shi M, Lin TH, Appell KC, Berg LJ. Janus-kinase-3-dependent Signals Induce Chromatin Remodeling at the ifng Locus during T Helper 1 Cell Differentiation. Immunity. 2008; 28(6):763-73.
    View PubMed
  110. Shi M, Zhang Y, Shen K, Lang J, Huang H, Wu M. [Clinical characteristics of clear cell carcinoma of the ovary]. Zhonghua Fu Chan Ke Za Zhi. 2002 Mar; 37 (3):161-3
    View PubMed
  111. Shi M, Shen K. The Clinical Application and Development of Cervical Conization. Clinical Journal of Obstetrics and Gynecology. 2001; 36(5):316-17.
  112. Shen K, Shi M, Lang J. Cervical Conization in Diagnosis and Management of Cervical Intraepithelial Neoplasia. Clinical Journal of Obstetrics and Gynecology. 2001; 36(5):264-66.
  113. Gao J, Shi M, Bian XM. Psoriasis in Pregnancy and the Outcome of the Pregnancy - Analysis of 3 Patients. Chinese Journal of Practical Gynecology and Obstetrics. 1999; 15(1):55-56.
  114. Shi M, He Y, Lang J. HPV Infection and Cervical Intraepithelial Neoplasia: the Current Diagnosis and Management of HPV Infection. Foreign Medical Sciences-section of Gynecology and Obstetrics. 1997; 24(5):284-87.
PST-20514699